Assignee
RIGSHOSPITALET
DK·14 granted patents·30 pending applications·46 citations·filing 2000–2025
Top patents by PatentIndex Score
44 records- 0188US10111969B2uPAR targeting peptide for use in peroperative optical imaging of invasive cancerRIGSHOSPITALET·Filed 2015·Granted Oct 30, 2018·7 cites·3 claims
- 0286US9433589B2Injectable pharmaceutical compositions comprising adrenaline and citric acidRIGSHOSPITALET·Filed 2014·Granted Sep 6, 2016·12 cites·17 claims
- 0384US9573984B2Chimeric inhibitor molecules of complement activationRIGSHOSPITALET·Filed 2014·Granted Feb 21, 2017·6 cites·13 claims
- 0478US9381243B2Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereofRIGSHOSPITALET·Filed 2014·Granted Jul 5, 2016·5 cites·13 claims
- 0572US7807379B2Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer markerRIGSHOSPITALET·Filed 2006·Granted Oct 5, 2010·3 cites·29 claims
- 0671US10940213B2Antibody-drug conjugates targeting uPARAPRIGSHOSPITALET·Filed 2017·Granted Mar 9, 2021·1 cites·10 claims
- 0771US7108983B1Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer markerRIGSHOSPITALET·Filed 2000·Granted Sep 19, 2006·11 cites·19 claims
- 0870US2024226317A9ANTIBODY-DRUG CONJUGATES TARGETING uPARAPRIGSHOSPITALET·Filed 2023·Application pending·0 cites
- 0963US2025176944A1A three dimensional ultrasound imaging device, related system, reference element, and methodRIGSHOSPITALET·Filed 2023·Application pending·0 cites
- 1060US10294286B2Chimeric inhibitor molecules of complement activationRIGSHOSPITALET·Filed 2017·Granted May 21, 2019·0 cites·10 claims
- 1159US11819552B2Antibody-drug conjugates targeting uPARAPRIGSHOSPITALET·Filed 2021·Granted Nov 21, 2023·0 cites·15 claims
- 1258US2025148598A1Image information processing apparatus, image information processing method, and non-transitory computer readable mediumRIGSHOSPITALET·Filed 2024·Application pending·0 cites
- 1358US2025148743A1Image information processing apparatus, image information processing method, and non-transitory computer readable mediumRIGSHOSPITALET·Filed 2024·Application pending·0 cites
- 1457US2026007702A1Stem cell therapy based on adipose-derived stem cellsRIGSHOSPITALET·Filed 2025·Application pending·0 cites
- 1556US2024241111A1Diagnosing and treating critically ill subjectsRIGSHOSPITALET·Filed 2022·Application pending·0 cites
- 1655US2025304939A1Tailored anti-fungal drugs and tools to diagnose invasive fungal infectionsRIGSHOSPITALET·Filed 2023·Application pending·0 cites
- 1755US2019125903A1Upar targeting peptide for use in peroperative optical imaging of invasive cancerRIGSHOSPITALET·Filed 2018·Application pending·0 cites
- 1854US2008261246A1Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancerRIGSHOSPITALET·Filed 2008·Application pending·0 cites
- 1953US2022401411A1Zafirlukast derivatives for use as contraceptive agentsRIGSHOSPITALET·Filed 2020·Application pending·0 cites
- 2053US2016303040A1Injectable pharmaceutical compositions comprising prostacyclinRIGSHOSPITALET·Filed 2014·Application pending·0 cites
- 2152US2025302977A1Antibody-drug conjugates comprising humanized antibodies targeting urokinase type plasminogen activator receptor associated protein (uparap)RIGSHOSPITALET·Filed 2022·Application pending·0 cites
- 2252US2023386113A1Medical image processing apparatus and medical image processing methodRIGSHOSPITALET·Filed 2023·Application pending·0 cites
- 2350US2011060529A1Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer markerRIGSHOSPITALET·Filed 2010·Application pending·0 cites
- 2449US7374886B2Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancerRIGSHOSPITALET·Filed 2002·Granted May 20, 2008·1 cites·31 claims
- 2549US2023022032A1uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPYRIGSHOSPITALET·Filed 2020·Application pending·0 cites
- 2648US12521454B268Ga- and 64Cu-NODAGA-E[c(RGDyK)]2 for use as PET tracers in the imaging of angiogenesis in humansRIGSHOSPITALET·Filed 2018·Granted Jan 13, 2026·0 cites·5 claims
- 2748US2016158392A1Entrapment of Radionuclides in Nanoparticle CompositionsRIGSHOSPITALET·Filed 2015·Application pending·0 cites
- 2847US2024287104A1Nuclide labelled h-tetrazines and use thereof for pet and spect pretargeted imaging and radionuclide therapyRIGSHOSPITALET·Filed 2021·Application pending·0 cites
- 2947US2015376294A1Anti-pad2 antibodies and treatment of autoimmune diseasesRIGSHOSPITALET·Filed 2013·Application pending·0 cites
- 3047US2022175255A1A system and a method for measuring volumetric flow in arteriesRIGSHOSPITALET·Filed 2020·Application pending·0 cites
- 3146US2022401585A1A urokinase plasminogen activator receptor-targeting peptideRIGSHOSPITALET·Filed 2020·Application pending·0 cites
- 3245US2015057325A1Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrestRIGSHOSPITALET·Filed 2013·Application pending·0 cites
- 3345US2023201383A1Psma targeting urea-based ligands for prostate cancer radiotherapy and imagingRIGSHOSPITALET·Filed 2021·Application pending·0 cites
- 3445US2023310643A1Extracorporeal clearing traps based on inverse electron demand diels-alder cycloaddition for (pre)-targeted therapy and diagnosticsRIGSHOSPITALET·Filed 2021·Application pending·0 cites
- 3543US12226495B218F-labeled novel tetrazines imaging probes for pretargeting in PET imagingRIGSHOSPITALET·Filed 2020·Granted Feb 18, 2025·0 cites·10 claims
- 3641US11203622B2MASP isoforms as inhibitors of complement activationRIGSHOSPITALET·Filed 2017·Granted Dec 21, 2021·0 cites·9 claims
- 3740US12433916B2Cell bank of high concentration adipose-derived stem cell composition and related methodsRIGSHOSPITALET·Filed 2016·Granted Oct 7, 2025·0 cites·13 claims
- 3839US2018356479A1Device for Reducing Magnetic Susceptibility ArtifactRIGSHOSPITALET·Filed 2016·Application pending·0 cites
- 3938US2019015532A1Quantitative pet imaging of tissue factor expression using 18f-labled active site inhibited factor viiRIGSHOSPITALET·Filed 2017·Application pending·0 cites
- 4038US2024094221A1Method for predicting the fertility potential of a female subjectRIGSHOSPITALET·Filed 2021·Application pending·0 cites
- 4135US2021094891A11-step radiosynthesis of [18f]sfbRIGSHOSPITALET·Filed 2019·Application pending·0 cites
- 4235US2021260203A1Polypept(o)id-based graft copolymers for in vivo imaging by tetrazine transyclooctene click chemistryRIGSHOSPITALET·Filed 2019·Application pending·0 cites
- 4332US2016250164A1Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strengthRIGSHOSPITALET·Filed 2015·Application pending·0 cites
- 4432US2011070601A1Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40RIGSHOSPITALET·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RIGSHOSPITALET files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →